Cite

HARVARD Citation

    Welch, J. et al. (n.d.). A phase I dose escalation study of oral bexarotene in combination with intravenous decitabine in patients with AML. American journal of hematology. 89 (8), pp. E103-E108. [Online]. 
  
Back to record